BPH Global Ltd (BP8.AX)
- Previous Close
0.0010 - Open
0.0010 - Bid --
- Ask 0.0010 x --
- Day's Range
0.0010 - 0.0010 - 52 Week Range
0.0010 - 0.0040 - Volume
19,628 - Avg. Volume
3,091,995 - Market Cap (intraday)
1.954M - Beta (5Y Monthly) 0.89
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Feb 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Malaysia. Its products include Caulerpa Lentillifera, a sea grape extract; Dendrobium Officinale Kimura et Migo, an orchid; Resina, a Daemonorops Draco Blume extract; and Cannabis Sativa, an industrial hemp. The company was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023. BPH Global Ltd was incorporated in 1984 and is headquartered in Melbourne, Australia.
www.scu.com.sg--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Recent News: BP8.AX
Performance Overview: BP8.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BP8.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BP8.AX
Valuation Measures
Market Cap
1.95M
Enterprise Value
1.76M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.44k
Price/Book (mrq)
91.17
Enterprise Value/Revenue
5.19k
Enterprise Value/EBITDA
-0.81
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-88.80%
Return on Equity (ttm)
-745.91%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-2.56M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
368.09k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.15M
Company Insights: BP8.AX
BP8.AX does not have Company Insights